Peptide linkers comprising two or more payloads
AssigneeAraris Biotech AG
InventorsRomain BERTRAND, Isabella ATTINGER-TOLLER, Rachael FAY, Dragan GRABULOVSKI, Philipp SPYCHER
Life of this patent
Estimating the term…
Loading patent…
AssigneeAraris Biotech AG
InventorsRomain BERTRAND, Isabella ATTINGER-TOLLER, Rachael FAY, Dragan GRABULOVSKI, Philipp SPYCHER
Estimating the term…
The present invention relates to a peptide linker comprising (a) an amino acid residue comprising a primary amine; and (b) two or more payloads; wherein each of the two or more payloads can be independently attached to: (i) an N-terminal end of the peptide linker, (ii) a C-terminal end of the peptide linker, or (iii) a side chain of an amino acid residue comprised in the peptide linker. Further, the present invention relates to antibody-payload conjugates comprising the peptide linker of the invention, methods for generating said antibody-payload conjugates and uses thereof.
A peptide linker comprising
11-19. (canceled)
(canceled)
24-28. (canceled)
An antibody-payload conjugate comprising an antibody conjugated to a peptide linker comprising
(canceled)
(canceled)
36-37. (canceled)
40-42. (canceled)
A method for the preparation of an antibody-payload conjugate comprising a step of conjugating a peptide linker to an antibody, wherein the peptide linker comprises
A method for the conjugation of a peptide linker comprising two or more payloads to an antibody using a transglutaminase (TG), the method comprising a) mixing the antibody, the peptide linker and the TG within a fluid, thereby conjugating the linker-payload to the antibody in one step under the catalyzing effect of the TG, and b) extracting the conjugate obtained in step a) from the fluid.
45-69. (canceled)
-81. (canceled)
A method of treating or preventing a neoplastic disease, said method comprising administering to a patient in need thereof an antibody-payload conjugate comprising an antibody conjugated to a peptide linker comprising
Dependencies are inferred from the claim text.